2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Identifiers

IUPAC Name

(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]pentanedioic acid

InChIKey

KOSRFJWDECSPRO-WDSKDSINSA-N

SMILES

C(CC(=O)O)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)N

Synonyms (40)

EE dipeptide
Glu-glu
Glutamate Glutamate dipeptide
Glutamyl-glutamic acid
H-GLU-GLU-OH
H-L-Glu-L-Glu-OH
L-Glu-L-Glu
L-Glutamyl-L-glutamic acid
L-a-Glutamyl-L-glutamate
L-a-Glutamyl-L-glutamic acid
L-alpha-Glutamyl-L-glutamate
L-glutamyl-L-glutamate
N-Glutamylglutamate
N-Glutamylglutamic acid
N-L-Glutamyl-L-glutamate
N-L-Glutamyl-L-glutamic acid
N-L-alpha-Glutamylglutamate
N-alpha-Glutamylglutamate
N-alpha-Glutamylglutamic acid
alpha-Glu-glu
alpha-Glutamylglutamate
alpha-L-Glu-L-glu
alpha-L-Glutamyl-L-glutamate
alpha-glutamylglutamic acid
glutamylglutamate

Sourcing Glu-glu?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request Supplier? List your product for this CAS